{
  "id": [
    "32571730"
  ],
  "source": [
    "MED"
  ],
  "pmid": [
    "32571730"
  ],
  "pmcid": [
    "PMC7298486"
  ],
  "fullTextIdList": [
    {
      "fullTextId": [
        "PMC7298486"
      ]
    }
  ],
  "doi": [
    "10.1016/j.reuma.2020.06.003"
  ],
  "title": [
    "Anakinra as a potential alternative in the treatment of severe acute respiratory infection associated with SARS-CoV-2 refractory to tocilizumab."
  ],
  "authorString": [
    "Figuero-Pérez L, Olivares-Hernández A, Escala-Cornejo RA, Terán-Brage E, López-Gutiérrez Á, Cruz-Hernández JJ."
  ],
  "authorList": [
    {
      "author": [
        {
          "fullName": [
            "Figuero-Pérez L"
          ],
          "firstName": [
            "Luis"
          ],
          "lastName": [
            "Figuero-Pérez"
          ],
          "initials": [
            "L"
          ],
          "authorAffiliationsList": [
            {
              "authorAffiliation": [
                "Servicio de Oncología Médica, Complejo Universitario de Salamanca, Salamanca, España; Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, España. Electronic address: figuero44@gmail.com."
              ]
            }
          ]
        },
        {
          "fullName": [
            "Olivares-Hernández A"
          ],
          "firstName": [
            "Alejandro"
          ],
          "lastName": [
            "Olivares-Hernández"
          ],
          "initials": [
            "A"
          ],
          "authorAffiliationsList": [
            {
              "authorAffiliation": [
                "Servicio de Oncología Médica, Complejo Universitario de Salamanca, Salamanca, España; Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, España."
              ]
            }
          ]
        },
        {
          "fullName": [
            "Escala-Cornejo RA"
          ],
          "firstName": [
            "Roberto A"
          ],
          "lastName": [
            "Escala-Cornejo"
          ],
          "initials": [
            "RA"
          ],
          "authorAffiliationsList": [
            {
              "authorAffiliation": [
                "Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, España; Servicio de Oncología Médica, Complejo Universitario de Ávila, Ávila, España."
              ]
            }
          ]
        },
        {
          "fullName": [
            "Terán-Brage E"
          ],
          "firstName": [
            "Eduardo"
          ],
          "lastName": [
            "Terán-Brage"
          ],
          "initials": [
            "E"
          ],
          "authorAffiliationsList": [
            {
              "authorAffiliation": [
                "Servicio de Oncología Médica, Complejo Universitario de Salamanca, Salamanca, España; Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, España."
              ]
            }
          ]
        },
        {
          "fullName": [
            "López-Gutiérrez Á"
          ],
          "firstName": [
            "Álvaro"
          ],
          "lastName": [
            "López-Gutiérrez"
          ],
          "initials": [
            "Á"
          ],
          "authorAffiliationsList": [
            {
              "authorAffiliation": [
                "Servicio de Oncología Médica, Complejo Universitario de Salamanca, Salamanca, España; Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, España."
              ]
            }
          ]
        },
        {
          "fullName": [
            "Cruz-Hernández JJ"
          ],
          "firstName": [
            "Juan J"
          ],
          "lastName": [
            "Cruz-Hernández"
          ],
          "initials": [
            "JJ"
          ],
          "authorAffiliationsList": [
            {
              "authorAffiliation": [
                "Servicio de Oncología Médica, Complejo Universitario de Salamanca, Salamanca, España; Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, España."
              ]
            }
          ]
        }
      ]
    }
  ],
  "dataLinksTagsList": [
    {
      "dataLinkstag": [
        "altmetrics"
      ]
    }
  ],
  "journalInfo": [
    {
      "journalIssueId": [
        "2964259"
      ],
      "dateOfPublication": [
        "2020 Jun"
      ],
      "monthOfPublication": [
        "6"
      ],
      "yearOfPublication": [
        "2020"
      ],
      "printPublicationDate": [
        "2020-06-01"
      ],
      "journal": [
        {
          "title": [
            "Reumatologia clinica"
          ],
          "ISOAbbreviation": [
            "Reumatol Clin"
          ],
          "medlineAbbreviation": [
            "Reumatol Clin"
          ],
          "NLMid": [
            "101293923"
          ],
          "ISSN": [
            "1699-258X"
          ],
          "ESSN": [
            "1885-1398"
          ]
        }
      ]
    }
  ],
  "pubYear": [
    "2020"
  ],
  "abstractText": [
    "SARS-CoV-2 is a new RNA virus which causes coronavirus disease 2019 (COVID-19), declared a pandemic by the World Health Organization (WHO). It triggers an atypical pneumonia that can progress to multiorgan failure. COVID-19 can cause dysregulation of the immune system, triggering an inflammatory response, and simulate haemophagocytic lymphohistiocytosis. Several studies have proposed that anti-IL-6 receptor antibodies, such as tocilizumab, play an important role in the treatment of severe acute respiratory infection associated with SARS-CoV-2. However, the role of anti-IL-1 receptor antibodies, such as anakinra, in the treatment of COVID-19 has not been established. We present a case report of a 51-year-old man diagnosed with severe respiratory infection associated with SARS-CoV-2 that was refractory to antiviral and anti-IL-6 treatment, with a favourable clinical outcome and analytical improvement after treatment with anti-IL-1 (anakinra)."
  ],
  "affiliation": [
    "Servicio de Oncología Médica, Complejo Universitario de Salamanca, Salamanca, España; Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, España. Electronic address: figuero44@gmail.com."
  ],
  "publicationStatus": [
    "aheadofprint"
  ],
  "language": [
    "eng"
  ],
  "pubModel": [
    "Print-Electronic"
  ],
  "pubTypeList": [
    {
      "pubType": [
        "research-article",
        "Journal Article"
      ]
    }
  ],
  "keywordList": [
    {
      "keyword": [
        "Tocilizumab",
        "Anakinra",
        "Cytokine Storm",
        "Sars-cov-2",
        "Tormenta De Citocinas"
      ]
    }
  ],
  "subsetList": [
    {
      "subset": [
        {
          "code": [
            "IM"
          ],
          "name": [
            "Index Medicus"
          ]
        }
      ]
    }
  ],
  "fullTextUrlList": [
    {
      "fullTextUrl": [
        {
          "availability": [
            "Subscription required"
          ],
          "availabilityCode": [
            "S"
          ],
          "documentStyle": [
            "doi"
          ],
          "site": [
            "DOI"
          ],
          "url": [
            "https://doi.org/10.1016/j.reuma.2020.06.003"
          ]
        },
        {
          "availability": [
            "Open access"
          ],
          "availabilityCode": [
            "OA"
          ],
          "documentStyle": [
            "html"
          ],
          "site": [
            "Europe_PMC"
          ],
          "url": [
            "https://europepmc.org/articles/PMC7298486"
          ]
        },
        {
          "availability": [
            "Open access"
          ],
          "availabilityCode": [
            "OA"
          ],
          "documentStyle": [
            "pdf"
          ],
          "site": [
            "Europe_PMC"
          ],
          "url": [
            "https://europepmc.org/articles/PMC7298486?pdf=render"
          ]
        }
      ]
    }
  ],
  "isOpenAccess": [
    "Y"
  ],
  "inEPMC": [
    "Y"
  ],
  "inPMC": [
    "N"
  ],
  "hasPDF": [
    "Y"
  ],
  "hasBook": [
    "N"
  ],
  "hasSuppl": [
    "N"
  ],
  "citedByCount": [
    "0"
  ],
  "hasData": [
    "N"
  ],
  "hasReferences": [
    "Y"
  ],
  "hasTextMinedTerms": [
    "Y"
  ],
  "hasDbCrossReferences": [
    "N"
  ],
  "hasLabsLinks": [
    "Y"
  ],
  "authMan": [
    "N"
  ],
  "epmcAuthMan": [
    "N"
  ],
  "nihAuthMan": [
    "N"
  ],
  "hasTMAccessionNumbers": [
    "N"
  ],
  "dateOfCreation": [
    "2020-06-24"
  ],
  "firstIndexDate": [
    "2020-06-24"
  ],
  "fullTextReceivedDate": [
    "2020-07-10"
  ],
  "dateOfRevision": [
    "2020-09-09"
  ],
  "electronicPublicationDate": [
    "2020-06-17"
  ],
  "firstPublicationDate": [
    "2020-06-17"
  ]
}